Immunotherapy for Hematologic Cancers

The "Immunotherapy for Hematologic Cancers" session will explore the revolutionary impact of immune-based treatments, such as CAR-T cell therapy and checkpoint inhibitors, in combating blood cancers. Renowned immunologists and clinicians will share their experiences and research, focusing on the potential and challenges of immunotherapy in achieving durable remissions and improving long-term outcomes for patients.

Key Topics:

  • CAR-T Cell Therapy Innovations: Advances in engineering T cells for enhanced efficacy and reduced toxicity.
  • Checkpoint Inhibitors in Blood Cancers: Current progress and ongoing trials in leveraging immune checkpoints.
  • Combination Immunotherapy Approaches: Synergizing immunotherapy with other modalities to overcome resistance.

    Related Conference of Immunotherapy for Hematologic Cancers

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Immunotherapy for Hematologic Cancers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in